Evidence map›Paper›PMID 38899601›Full record

ArticleVirulence2024

A shared mechanism of multidrug resistance in laboratory-evolved uropathogenic

Nakjun Choi, Eunna Choi, Yong-Joon Cho, Min Jung Kim, Hae Woong Choi, Eun-Jin Lee

Abstract read
In one paragraph

Article in Virulence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Antimicrobial efficacy of carbon nanotube-based nano drug onBiochemistry and biophysics reports · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Current Insights into Antibiotic Resistance in UropathogenicAntibiotics (Basel, Switzerland) · 2025
    Review
  8. UropathogenicInternational journal of molecular sciences · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Development and application of a quadruplexFrontiers in cellular and infection microbiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nakjun ChoiDepartment of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Eunna ChoiDepartment of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Yong-Joon ChoDepartment of Molecular Bioscience, Multidimensional Genomics Research Center, College of Biomedical Science, Kangwon National University, Chuncheon, South Korea.
Min Jung KimDepartment of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Hae Woong ChoiDepartment of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.
Eun-Jin LeeDepartment of Life Sciences, School of Life Sciences and Biotechnology, Korea University, Seoul, South Korea.ORCID 0000-0001-5078-1974

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of multidrug-resistant bacteria poses a significant threat to human health, necessitating a comprehensive understanding of their underlying mechanisms. Uropathogenic

Indexed as

AmpicillinAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialEscherichia coli InfectionsMutationUrinary Tract InfectionsUropathogenic Escherichia coliAnimalsEscherichia coli ProteinsFemaleHumansMiceMicrobial Sensitivity TestsWhole Genome SequencingAmpicillinAnti-Bacterial AgentsEscherichia coli ProteinsadhesionAntibiotic resistanceefflux pumptype 1 fimbriaeuropathogenic Escherichia coli

Identifiers

PMID38899601
PMCPMC11195483

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.